Crescendo Biologics

Showing 5 posts of 5 posts found.


Crescendo Biologics selects current CFO Theodora Harold as new CEO

April 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Cambridge, Crescendo Biologics, Dr Peter Pack, Theo Harold, cfo

Cambridge, UK-based Crescendo Biologics have said current Chief Financial Officer (CFO) Theodora Harold will take over from Dr Peter Pack …


Takeda unveils three new discovery and development collaborations in immuno-oncology

January 4, 2019
Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma

Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …


Takeda enters $790m cancer development deal

October 11, 2016
Manufacturing and Production, Research and Development Cancer, Crescendo Biologics, Takeda, clinical partnership, humabody

Takeda and Crescendo Biologics have shaken hands on a $790 million deal to develop and commercialise cancer therapeutics using Crescendo’s …


Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property

February 2, 2016
Research and Development Crescendo Biologics

Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …


Clive Dix appointed chairman of Crescendo Biologics

January 21, 2010
Research and Development Crescendo Biologics, appointment, research and development

Cambridge, UK-based Crescendo Biologics has appointed Clive Dix as chairman. He will work closely with chief scientific officer Mike Romanos …

Latest content